Freezing of gait (FOG) is a devastating axial motor symptom in Parkinson's disease (PD) leading to falls, institutionalization, and even death. The response of FOG to dopaminergic medication and deep brain stimulation (DBS) is complex, variable, and yet to be optimized. Fundamental gaps in the knowledge of the underlying neurobiomechanical mechanisms of FOG render this symptom one of the unsolved challenges in the treatment of PD. Subcortical neural mechanisms of gait impairment and FOG in PD are largely unknown due to the challenge of accessing deep brain circuitry and measuring neural signals in real time in freely-moving subjects. Additionally, there is a lack of gait tasks that reliably elicit FOG. Since FOG is episodic, we hypothesized that dynamic features of subthalamic (STN) beta oscillations, or beta bursts, may contribute to the Freezer phenotype in PD during gait tasks that elicit FOG. We also investigated whether STN DBS at 60 Hz or 140 Hz affected beta burst dynamics and gait impairment differently in Freezers and Non-Freezers. Synchronized STN local field potentials, from an implanted, sensing neurostimulator (Activa® PC + S, Medtronic, Inc.), and gait kinematics were recorded in 12 PD subjects, off-medication during forward walking and stepping-in-place tasks under the following randomly presented conditions: NO, 60 Hz, and 140 Hz DBS. Prolonged movement band beta burst durations differentiated Freezers from Non-Freezers, were a pathological neural feature of FOG and were shortened during DBS which improved gait. Normal gait parameters, accompanied by shorter bursts in NonFreezers, were unchanged during DBS. The difference between the mean burst duration between hemispheres (STNs) of all individuals strongly correlated with the difference in stride time between their legs but there was no correlation between mean burst duration of each STN and stride time of the contralateral leg, suggesting an interaction between hemispheres influences gait. These results suggest that prolonged STN beta burst durations measured during gait is an important biomarker for FOG and that STN DBS modulated long not short burst durations, thereby acting to restore physiological sensorimotor information processing, while improving gait.
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Introduction
Axial motor symptoms of Parkinson's disease (PD) such as freezing of gait (FOG) and postural instability are major reasons for loss of autonomy, falls, institutionalization, and death in patients with PD (Giladi et al., 1992 (Giladi et al., , 1997 Bloem et al., 2004; Vervoort et al., 2016) . FOG frequently manifests as patients attempt to initiate walking, turning, and while navigating obstacles. It results in life-threatening falls or sudden immobility that renders patients helpless in dangerous situations such as crossing a street. The response of FOG to treatment is complex, variable, and has yet to be optimized. Both dopaminergic medication and subthalamic nucleus (STN) deep brain stimulation (DBS) at low and high frequencies may improve FOG, suggesting that neural mechanisms underlying FOG reside within the sensorimotor networks accessed by both medication and DBS (Moreau et al., 2008; Sidiropoulos et al., 2013; Annic et al., 2014; Khoo et al., 2014; Nantel and Bronte-Stewart, 2014; Vercruysse et al., 2014; Fasano et al., 2015; Xie et al., 2015) . However, PD patients may still develop FOG while on medication and/or DBS even while the other cardinal motor signs of PD (tremor, rigidity, and bradykinesia) are well-treated (Lilleeng et al.,
